Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing Total Pancreatectomy and Autologous Islet Transplantation: A Clinical, Molecular, and Genomic Study

NCT03283566 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03283566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03283566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing Total Pancreatectomy and Autologous Islet Transplantation: A Clinical, Molecular, and Genomic Study
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Completed
Start date
October 3, 2017
Completion date
May 31, 2020
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pancreatitis, insulin dependent diabetes